Show simple item record

dc.contributor.authorTalay, M. B.
dc.contributor.authorSeggie, Steven Head
dc.contributor.authorCavusgil, E.
dc.date.accessioned2010-08-24T09:54:46Z
dc.date.available2010-08-24T09:54:46Z
dc.date.issued2009-07
dc.identifier.issn1540-5885
dc.identifier.urihttp://onlinelibrary.wiley.com/doi/10.1111/j.1540-5885.2009.00665.x/abstract
dc.identifier.urihttp://hdl.handle.net/10679/83
dc.description.abstractThis paper examines collaborative ventures leading toward the launch of new products in the pharmaceutical industry. These collaborative ventures are one of the most underresearched areas in the new product literature, yet the preponderance of these collaborative ventures makes it an area of great importance for scholars and practitioners alike. As such, the purpose of the study is to examine why some collaborative projects produce a favorable outcome (the launch of a product) whereas others do not. That is, what characteristics of partner firms in the collaborative ventures and what characteristics of the partnership lead to a successful launch of a new product in the pharmaceutical industry? Secondary data from the pharmaceutical industry are employed in a multinomial logit model. Data from 128 collaborative ventures from 1980 to 2004 are used in the analysis. The partner firms in the collaborative ventures are from various industries ranging from malt beverages to pharmaceutical preparations to electronic and other equipment among others. Of the 128 collaborative ventures, 66 were successful in leading to a new product launch, whereas 62 did not result in the launch of a new product. The results from the multinomial logit analysis suggest that combined marketing resources of parent companies, combined technological intensity of parent companies, and combined asset bases of parent companies contribute to the likelihood of an eventual product launch in a collaborative venture. However, the results of the analysis show that contrary to expectations, technological complementarity of partners in the collaborative venture is not a significant predictor of successful new product launch. The results of the study suggest certain aspects for managers to consider when establishing collaborative ventures. To maximize the possibilities of the collaborative venture leading to the successful launching of a new product, managers should be concerned with the resources potentially available to partners in the collaborative venture from parent firms. These resources are not only of a financial but also of a technological nature. The existence of these resources does not ensure provision of resources to the collaborative venture; however, without the possibility of these resources it appears that successful launch of a product is less likely.en_US
dc.language.isoengen_US
dc.publisherWileyen_US
dc.relation.ispartofJournal of Product Innovation Management
dc.rightsrestrictedAccess
dc.titleExploring correlates of product launch in collaborative ventures: an empirical investigation of pharmaceutical alliancesen_US
dc.typeArticleen_US
dc.peerreviewedyesen_US
dc.publicationstatuspublisheden_US
dc.contributor.departmentÖzyeğin University
dc.contributor.authorID25900
dc.contributor.ozuauthorSeggie, Steven Head
dc.identifier.volume26
dc.identifier.issue4
dc.identifier.startpage360
dc.identifier.endpage370
dc.identifier.wosWOS:000265773800002
dc.identifier.doi10.1111/j.1540-5885.2009.00665.x
dc.subject.keywordsPharmaceutical alliancesen_US
dc.subject.keywordsPharmaceutical industryen_US
dc.contributor.authorMale1


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record


Share this page